PathAI

OverviewSuggest Edit

PathAI is a company developing an AI-based platform technology for data-driven pathology analysis. It provides research and drug development, clinical, and global health solutions. The platform helps to deliver standardized pathologic diagnoses.
TypePrivate
Founded2016
HQBoston, MA, US
Websitepathai.com
Employee Ratings4.4

Latest Updates

Employees (est.) (May 2022)345(+7%)
Job Openings98
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at PathAI

Andrew H. Beck

Andrew H. Beck

Co-Founder & CEO
Aditya Khosla

Aditya Khosla

Co-Founder & CTO
Andy Moffit

Andy Moffit

Chief People Officer
Tiffany Freitas

Tiffany Freitas

Chief Financial Officer
Liz Storti

Liz Storti

VP of Finance and Operations
Joe Adu

Joe Adu

Director of Information Technology and Security
Show more

PathAI Office Locations

PathAI has offices in Boston and Austin
Boston, MA, US (HQ)
120 Brookline Ave
Austin, TX, US
316 W 12th St 6th Floor
Boston, MA, US
1325 Boylston St
Show all (3)

PathAI Financials and Metrics

Summary Metrics

Founding Date

2016

PathAI total Funding

$255.2 m

PathAI latest funding size

$165 m

Time since last funding

a year ago

PathAI investors

PathAI's latest funding round in May 2021 was reported to be $165 m. In total, PathAI has raised $255.2 m
Show all financial metrics

PathAI Operating Metrics

Sep, 2020

Patents (US)

2

PathAI Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

PathAI Online and Social Media Presence

Embed Graph

PathAI Company Culture

  • Compensation

    A+

    100/100

Learn more on Comparably

PathAI News and Updates

Cleveland Clinic and PathAI partner to identify diseases and offer treatment

PathAI and Cleveland Clinic aim to change that have embarked on a five-year research collaboration. This partnership will involve digitizing pathology specimens and linking clinical data with digitized pathology data.

PathAI Partners with Datavant to enable Biopharma Companies to Connect Digital Pathology Data for Research

BOSTON and SAN FRANCISCO, March 17, 2022 (GLOBE NEWSWIRE) -- PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, and Datavant, the leader in helping organizations securely connect health data, announced a collaboration to enable compliant connectivity of PathA…

Akoya Biosciences Announces a Groundbreaking Collaboration with PathAI to Combine Spatial Biology with AI-Powered Tools to Facilitate Discovery of Novel Predictive Biomarkers

Partnership pairs Akoya’s spatial phenotyping solutions and PathAI’s AI-based algorithms to elucidate spatial biomarker signatures for biopharma partners Partnership pairs Akoya’s spatial phenotyping solutions and PathAI’s AI-based algorithms to elucidate spatial biomarker signatures for biopharma p…

PathAI Composite PD-L1 and AI-powered CD8+ Topology Biomarker May Improve Prediction of Immuno-Oncology Treatment Response in Patients with Melanoma at the Society for Immunotherapy of Cancer Meeting 2021

BOSTON, Nov. 12, 2021 /PRNewswire/ -- PathAI, a global provider of AI-powered technology applied to pathology announced that results from a recent exploratory biomarker analysis on digitized slides to apply AI-predicted CD8 topology assessment of patients with advanced melanoma will be...

PathAI and Novo Nordisk present AI-powered scoring showing significant reduction of fibrosis following semaglutide treatment in patients with NASH

BOSTON, Nov. 10, 2021 /PRNewswire/ -- PathAI, a global leader of AI-powered technology applied to pathology, today announced new data showing AI-based assessment, including use of PathAI's AIM-NASH tool, of key histological features of non-alcoholic steatohepatitis (NASH) following...

PathAI Announces Strategic Partnership with Roche to Enable Development and Distribution of Digital Pathology Diagnostics

BOSTON, Oct. 15, 2021 /PRNewswire/ -- PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, and Roche, a global pioneer in pharmaceuticals and diagnostics, announced a strategic partnership to develop and distribute PathAI's AI-powered technology...
Show more

PathAI Frequently Asked Questions

  • When was PathAI founded?

    PathAI was founded in 2016.

  • Who are PathAI key executives?

    PathAI's key executives are Andrew H. Beck, Aditya Khosla and Andy Moffit.

  • How many employees does PathAI have?

    PathAI has 345 employees.

  • Who are PathAI competitors?

    Competitors of PathAI include Tempus, Prognos Health and HealthCode AI.

  • Where is PathAI headquarters?

    PathAI headquarters is located at 120 Brookline Ave, Boston.

  • Where are PathAI offices?

    PathAI has offices in Boston and Austin.

  • How many offices does PathAI have?

    PathAI has 3 offices.